Company profile

Celloryx AG (Aurealis Pharma Ltd.)

Aurealis Pharma, a privately-held biopharmaceutical company, has developed a broadly applicable technology platform that enables three-in-one combination therapy in one single product. This effective, safe and economical treatment method can greatly improve the quality of life of people suffering from these major unmet medical needs such as cancer.

More news about Celloryx AG (Aurealis Pharma Ltd.)

10.05.2023 09:00

Biotech startups turn gear into Phase 2 clinical trials

Please login or
register to use the
awards follow feature
04.04.2023 08:47

Aurealis Therapeutics banks $10 million in an oversubscribed round

Please login or
register to use the
awards follow feature
31.01.2022 10:20

Aurealis to receive up to $139 million in collaboration agreement

Please login or
register to use the
awards follow feature
12.02.2020 10:28

Aurealis Therapeutics startet 1-2A-Studie

Please login or
register to use the
awards follow feature
12.02.2019 08:32

Aurealis Pharma Announces CHF 7.8 Million Financing Round

Please login or
register to use the
awards follow feature
29.08.2017 16:40

Aurealis Pharma Announces 5.6MCHF Series A Financing

Please login or
register to use the
awards follow feature
Celloryx AG (Aurealis Pharma Ltd.)

Founded
2015

Kanton
BS

Homepage

rss